Abstract
The major surface antigen from the proliferative form ofToxoplasma gondii (P-30 or SAG-1) was chosen as a target for exploration ofToxoplasma gondii reactivation in sera from immunocompromised patients. Samples were obtained from 37 HIV-infected subjects with lymphocyte levels of CD4+ <200/mm3. The prevalence of IgG antibodies toToxoplasma gondii was 64.9 %. Ten patients had clinical symptoms of reactivated toxoplasmosis; eight of these hadToxoplasma encephalitis. The SAG-1 epitopes were found as circulating antigen in five cases with an immunocapture enzyme immunoassay (EIA). The EIA was improved with an IgG1 monoclonal antibody to SAG-1 and a streptavidinbiotin amplification. The sensitivity, specificity and positive predictive value were 30, 92 and 60 %, respectively. The SAG-1 levels were compared with different biological parameters such as HIV p24 antigen, β2 microglobulin, CD4+ cell count and IgG antibodies toToxoplasma gondii. The levels of SAG-1 in these patients were significantly higher than those in the 75 healthy control persons with or without a chronicToxoplasma gondii infection. Therefore, SAG-1 may be involved as a marker of reactivated toxoplasmosis in HIV-infected patients.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Frenkel JK: Adoptive immunity to intracellular infection. Journal of Immunology 1967, 98: 1309–1319.
Pavia CS: Protection against experimental toxoplasmosis by adoptive immunotherapy. Journal of Immunology 1986, 137: 2985–2990.
Luft BJ, Remington JS: AIDS commentary. Toxoplasmic encephalitis. Journal of Infectious Diseases 1988, 157: 1–16.
Gazzinelli RT, Hakim FT, Hieny S, Shearer GM, Sher A: Synergistic role of CD4+ and CD8+ T lymphocytes in IFN-γ production and protective immunity induced by an attenuatedToxoplasma gondii vaccine. Journal of Immunology 1991, 146: 286–292.
Araujo F: Depletion of L3T4+ (CD4+) T lymphocytes prevents development of resistance toToxoplasma gondii in mice. Infection and Immunity 1991, 59:1614–1619.
Rabaud C, May T, Amiel C, Katlama C, Leport C, Ambroise-Thomas P, Canton P: Extracerebral toxoplasmosis in patients infected with HIV. A French national survey. Medicine 1994, 73: 306–314.
Asai T, Kim T, Kobayashi M, Kojima S: Detection of nucleoside triphosphate hydroiase as a circulating antigen in sera of mice infected withToxoplasma gondii. Infection and Immunity 1987, 55: 1332–1335.
Acebes MV, Diez B, Garcia-Rodriguez JA, Viens P, Cisterna R: Detection of circulating antigens in the diagnosis of acute toxoplasmosis. American Journal of Tropical Medicine and Hygiene 1994, 51: 506–511.
Hassl A, Aspöck H, Flamm H: Evidence of structural proteins ofToxoplasma gondii in sera of experimentally infected mice. Zentralblatt für Bakteriologie und Hygiene (A) 1988, 270: 310–312.
Ise Y, Iida T, Sato K, Suzuki T, Shimada K, Nishioka K: Detection of circulating antigens in sera of rabbits infected withToxoplasma gondii. Infection and Immunity 1985, 48: 269–272.
Raizman RE, Neva FA: Detection of circulating antigen in acute experimental infections withToxoplasma gondii. Journal of Infectious Diseases 1975, 132: 44–48.
Hassl A, Aspöck H, Flamm H: Circulating antigens ofToxoplasma gondii in patients with AIDS. Zentralblatt für Bakteriologie und Hygiene (A) 1988, 270: 302–309.
Van Knapen F: Detection of circulating antigen during acute infections withToxoplasma gondii by enzymelinked immunosorbent assay. Journal of Clinical Microbiology 1977, 6: 545–547.
Shepp DH, Hackman RC, Conley FK, Anderson JB, Meyers JD:Toxoplasma gondii reactivation by detection of parasitemia in tissue culture. Annals of Internal Medicine 1985, 103: 218–221.
Turunen HJ: Detection of soluble antigens ofToxoplasma gondii by a four layer modification of an enzyme immunoassay. Journal of Clinical Microbiology 1983, 17: 768–773.
Burg JL, Perelman D, Kasper LH, Ware PL, Boothroyd JC: Molecular analysis of the gene encoding the major surface antigen ofToxoplasma gondii. Journal of Immunology 1988, 141: 3584–3591.
Pfefferkorn ER: Cell biology ofToxoplasma gondii. In: Wyler DJ (ed): Modern parasite biology: cellular, immunological and molecular aspects. Freeman, New York, 1990, p. 26–50.
Santoro F, Afchain FD, Pierce R, Cesbron JY, Ovlaque A, Capron A: Serodiagnosis of toxoplasma infection using a purified parasite-protein (P-30). Clinical and Experimental Immunology 1985, 62: 262–269.
Santoro F, Charif H, Capron A: The immunodominant epitope of the major membrane tachyzoite protein (P-30) ofToxoplasma gondii. Parasite Immunology 1986, 8: 631–639.
McLeod R, Mack D, Brown C:Toxoplasma gondii — new advances in cellular and molecular biology. Experimental Parasitology 1991, 72: 109–121.
Renversez JC, Sotto MF, Hollard D, Sotto JJ: Serum beta-2 microglobulin in the follow-up of chronic lymphocytic leukemia. In: Peters H (ed): Protides of the biological fluids. Pergamon Press, New York, 1984, p. 703–706.
Ambroise-Thomas P, Garin JP, Rigaud A: Amélioration de la technique d'immunofluorescence par l'emploi de contre-colorants. Application aux toxoplasmes. Presse Médicale 1966, 74: 2215–2216.
Desmonts G, Naot Y, Remington JS: Immunoglobulin M-immunosorbent agglutination assay for diagnosis of infectious diseases: diagnosis of acute congenital and acquiredToxoplasma infections. Journal of Clinical Microbiology 1981, 14: 486–491.
Chumpitazi BFF, Boussaid A, Pelloux H, Racinet C, Bost M, Goullier-Fleuret A: Diagnosis of congenital toxoplasmosis by immunoblotting and relationship with other methods. Journal of Clinical Microbiology 1995, 33: 1479–1485.
Grant IH, Gold JWM, Rosenblum M, Niedzwiecki D, Armstrong D:Toxoplasma gondii serology in HIV-infected patients: the development of central nervous system toxoplasmosis in AIDS. AIDS 1990, 4: 519–522.
Girard PM, Ladman R, Gaudebout C, Olivares R, Saimont AG, Jelazko P, Gaudebout C, Certain A, Boué F, Bouvet E, Lecompte T, Coulaud J-P, the PRIO Study Group: Dapsone-pyrimethamine compared with aerosolized pentamidine as primary prophylaxis againstPneumocystis carinii pneumonia and toxoplasmosis in HIV infection. New England Journal of Medicine 1993, 328: 1514–1520.
Rossitch E, Carrazana EJ, Samuels MA: Cerebral toxoplasmosis in patients with AIDS. American Family Physician 1990, 41: 867–873.
Siegel JP, Remington JS: Circulating immune complexes in toxoplasmosis: detection and clinical correlates. Clinical and Experimental Immunology 1983, 52: 157–163.
Grimwood J, Smith JE:Toxoplasma gondii: the role of a 30-kDa surface protein in host cell invasion. Experimental Parasitology 1992, 74: 106–111.
Dupouy-Camet J, Lavareda de Souza S, Maslo C, Paugam A, Saimot AG, Benarous R, Tourte-Schaefer C, Derouin F: Detection ofToxoplasma gondii in venous blood from AIDS patients by polymerase chain reaction. Journal of Clinical Microbiology 1993, 31: 1866–1869.
Cristina N, Pellour H, Goulhot C, Brion JP, Leclerq P, Ambroise-Thomas P: Detection ofToxoplasma gondii in AIDS patients by the polymerase chain reaction. Infection 1993, 21: 150–153.
Kasper LH: Isolation and characterization of a monoclonal anti P-30 antibody mutant ofToxoplasma gondii. Parasite Immunology 1987, 9: 433–445.
Bülow R, Boothroyd JC: Protection of mice from fatalToxoplasma gondii infection by immunization with P30 antigen in liposomes. Journal of Immunology 1991, 147: 3496–3500.
Stellbrink HJ, Führer-Burow R, Raedler A, Albrecht H, Fensk S: Risk factors for severe disease due toToxoplasma gondii in HIV-positive patients. European Journal of Epidemiology 1993, 9: 633–637.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Letillois, M.F., Laigle, V., Santoro, F. et al. Toxoplasma gondii surface antigen-1 in sera of HIV-infected patients as an indicator of reactivated toxoplasmosis. Eur. J. Clin. Microbiol. Infect. Dis. 14, 899–903 (1995). https://doi.org/10.1007/BF01691497
Issue Date:
DOI: https://doi.org/10.1007/BF01691497